Patents expiring in 2031

US 8034384

Method of increasing biocompatibility of medical device by generating nitric oxide

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 102010014113

Freisetzungsverfahren für Implantate

ACINO AG [DE] · Granted Thu Oct 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039661

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039623

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039620

Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039627

Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

Neurocrine Biosciences, Inc. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039579

Intermediates useful in the preparation of maleimide functionalized polymers

Nektar Therapeutics · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039489

Guanidine-containing compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039585

Therapeutic administration of the scrambled anti-angiogenic peptide C16Y

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039491

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039500

Fused heterocyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039475

Co-crystals and pharmaceutical compositions comprising the same

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8038997

Anti-marinobufagenin antibodies and methods for their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039003

Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039008

Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

The Board of Regents of the University of Texas System · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039257

Pre-transplant accomodated organs resistant to anti-donor immunity

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8039593

Antibodies and immunotoxins that target human glycoprotein NMB

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044018

Reagents and methods for smooth muscle therapies

THE ARIZONA BOARD OF REGENTS · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044054

Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043617

Human antibodies to human IL-6 receptor

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044259

Determining the capability of a test compound to affect solid tumor stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044236

Carboxilic acid derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043623

Immunogenic peptides for the treatment of prostate and breast cancer

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043820

Diagnostic methods for the detection of risk of autistic spectrum disorder

The Regents of the University of California · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043853

Postnatal gut neural crest stem cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044026

Composition for promoting cartilage formation or repair comprising a NELL gene product and method of treating cartilage-related conditions using such composition

The Regents of the University of California · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044045

Indazole-carboxamide compounds as 5-HT4 receptor agonists

Theravance, Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044057

Methods for suppressing an immune response or treating a proliferative disorder

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044049

Fused heterocyclic derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044093

Pharmaceutical compositions comprising docetaxel and methods for preparation thereof

Beijing Century Biocom Pharmaceutical Technology Co., Ltd. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044185

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to reveal cryptic V3-loop epitopes

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044187

Human luteinizing hormone superagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044195

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043625

Purified plasmodium and vaccine compositions

Sanaria Inc. · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044033

Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8044189

Bacillus anthracis protective antigen nucleic acid sequences

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8043622

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8049016

Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

Xenon Pharmaceuticals Inc. · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048432

Polysaccharide-protein conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048646

NELL peptide expression systems and bone formation activity of NELL peptide

The Regents of the University of California · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048427

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048415

Compositions and methods for promoting or inhibiting angiogenesis

Northwestern University · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048222

Highly pure modafinil

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048844

Preventing airway mucus production by administration of EGF-R antagonists

The Regents of the University of California · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048889

3,4-disubstituted coumarin and quinolone compounds

XTL BIOPHARMACEUTICALS LTD. · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048851

Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

The Regents of the University of California · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8048906

Optically pure and enriched isomers of chelating ligands and contrast agents

Catalyst Medical · Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)